Toprak, V.; Özdemir, İ.; Öztürk, Ş.; Yanar, O.; Kizildemir, Y.Z.; Tuncer, M.C.
Thymoquinone Enhances Doxorubicin Efficacy via RAS/RAF Pathway Modulation in Ovarian Adenocarcinoma. Pharmaceutics 2025, 17, 536.
https://doi.org/10.3390/pharmaceutics17040536
AMA Style
Toprak V, Özdemir İ, Öztürk Ş, Yanar O, Kizildemir YZ, Tuncer MC.
Thymoquinone Enhances Doxorubicin Efficacy via RAS/RAF Pathway Modulation in Ovarian Adenocarcinoma. Pharmaceutics. 2025; 17(4):536.
https://doi.org/10.3390/pharmaceutics17040536
Chicago/Turabian Style
Toprak, Veysel, İlhan Özdemir, Şamil Öztürk, Orhan Yanar, Yusuf Ziya Kizildemir, and Mehmet Cudi Tuncer.
2025. "Thymoquinone Enhances Doxorubicin Efficacy via RAS/RAF Pathway Modulation in Ovarian Adenocarcinoma" Pharmaceutics 17, no. 4: 536.
https://doi.org/10.3390/pharmaceutics17040536
APA Style
Toprak, V., Özdemir, İ., Öztürk, Ş., Yanar, O., Kizildemir, Y. Z., & Tuncer, M. C.
(2025). Thymoquinone Enhances Doxorubicin Efficacy via RAS/RAF Pathway Modulation in Ovarian Adenocarcinoma. Pharmaceutics, 17(4), 536.
https://doi.org/10.3390/pharmaceutics17040536